Saileta Prabhu, PhD

Clinical Pharmacologist at Regeneron

Speaker

Saileta Prabhu, PhD, is a clinical pharmacologist with expertise in translational PK/PD, dose selection, and biologics development. Previously at Genentech and currently at Regeneron Pharmaceuticals, she has contributed to the development of antibody therapeutics spanning discovery, translation, and clinical development. Her research interests include antibody-drug conjugates, bispecific antibodies, and innovative drug delivery approaches. She has contributed to the development and approval of multiple therapies, including polatuzumab vedotin and ocrelizumab.